UltraGreen.ai (SGX:ULG) was granted regulatory approval in Singapore for Verdye, an indocyanine green injection, according to a Tuesday filing with the Singapore Exchange.
The approval allows the company to ramp up its commercialization efforts and expand its partnerships with local healthcare institutions as part of the adoption of its fluorescence-guided technology.
The technology is used across multiple surgical procedures.
Shares of the healthcare intelligence company were down over 5% in Tuesday's late-morning trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments